Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses

Summary: Non-replicating rotavirus vaccines are an alternative strategy to improve the efficacy and safety of rotavirus vaccines. The spike protein VP4, which could be enzymatically cleaved into VP8∗ and VP5∗, is an ideal target for the development of recombinant rotavirus vaccine. In our previous s...

Full description

Bibliographic Details
Main Authors: Guoxing Luo, Yuanjun Zeng, Han Yang, Yijian Li, Lianwei Yang, Cao Li, Feibo Song, Shiyin Zhang, Tingdong Li, Shengxiang Ge, Jun Zhang, Ningshao Xia
Format: Article
Language:English
Published: Elsevier 2022-10-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004222013712
_version_ 1811204381149757440
author Guoxing Luo
Yuanjun Zeng
Han Yang
Yijian Li
Lianwei Yang
Cao Li
Feibo Song
Shiyin Zhang
Tingdong Li
Shengxiang Ge
Jun Zhang
Ningshao Xia
author_facet Guoxing Luo
Yuanjun Zeng
Han Yang
Yijian Li
Lianwei Yang
Cao Li
Feibo Song
Shiyin Zhang
Tingdong Li
Shengxiang Ge
Jun Zhang
Ningshao Xia
author_sort Guoxing Luo
collection DOAJ
description Summary: Non-replicating rotavirus vaccines are an alternative strategy to improve the efficacy and safety of rotavirus vaccines. The spike protein VP4, which could be enzymatically cleaved into VP8∗ and VP5∗, is an ideal target for the development of recombinant rotavirus vaccine. In our previous studies, we demonstrated that the truncated VP4 (aa26-476, VP4∗) could be a more viable vaccine candidate compared to VP8∗ and VP5∗. Here, to develop a human rotavirus vaccine, the VP4∗ proteins of P[4], P[6], and P[8] genotype rotaviruses were expressed. All VP4∗ proteins can stimulate high levels of neutralizing antibodies in both guinea pigs and rabbits when formulated in aluminum adjuvant. Furthermore, bivalent VP4∗-based vaccine (P[8] + P[6]-VP4∗) can stimulate high levels of neutralizing antibodies against various genotypes of rotavirus with no significant difference as compared to the trivalent vaccines. Therefore, bivalent VP4∗ has the potential to be a viable rotavirus vaccine candidate for further development.
first_indexed 2024-04-12T03:12:21Z
format Article
id doaj.art-7e88edbcc6dc4ee69cd2b0485b40d163
institution Directory Open Access Journal
issn 2589-0042
language English
last_indexed 2024-04-12T03:12:21Z
publishDate 2022-10-01
publisher Elsevier
record_format Article
series iScience
spelling doaj.art-7e88edbcc6dc4ee69cd2b0485b40d1632022-12-22T03:50:19ZengElsevieriScience2589-00422022-10-012510105099Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotavirusesGuoxing Luo0Yuanjun Zeng1Han Yang2Yijian Li3Lianwei Yang4Cao Li5Feibo Song6Shiyin Zhang7Tingdong Li8Shengxiang Ge9Jun Zhang10Ningshao Xia11State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen 361102, ChinaState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen 361102, ChinaState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen 361102, ChinaCollege of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, ChinaR&D Department of Xiamen Innodx Biotechnology Co., Ltd, Xiamen 361000, ChinaState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen 361102, ChinaNational Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences, Xiamen University, Xiamen 361102, ChinaState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen 361102, ChinaState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen 361102, China; Corresponding authorState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen 361102, China; Corresponding authorState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen 361102, ChinaState Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen 361102, China; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences, Xiamen University, Xiamen 361102, ChinaSummary: Non-replicating rotavirus vaccines are an alternative strategy to improve the efficacy and safety of rotavirus vaccines. The spike protein VP4, which could be enzymatically cleaved into VP8∗ and VP5∗, is an ideal target for the development of recombinant rotavirus vaccine. In our previous studies, we demonstrated that the truncated VP4 (aa26-476, VP4∗) could be a more viable vaccine candidate compared to VP8∗ and VP5∗. Here, to develop a human rotavirus vaccine, the VP4∗ proteins of P[4], P[6], and P[8] genotype rotaviruses were expressed. All VP4∗ proteins can stimulate high levels of neutralizing antibodies in both guinea pigs and rabbits when formulated in aluminum adjuvant. Furthermore, bivalent VP4∗-based vaccine (P[8] + P[6]-VP4∗) can stimulate high levels of neutralizing antibodies against various genotypes of rotavirus with no significant difference as compared to the trivalent vaccines. Therefore, bivalent VP4∗ has the potential to be a viable rotavirus vaccine candidate for further development.http://www.sciencedirect.com/science/article/pii/S2589004222013712Biological sciencesMicrobiologyVirologyViral microbiology
spellingShingle Guoxing Luo
Yuanjun Zeng
Han Yang
Yijian Li
Lianwei Yang
Cao Li
Feibo Song
Shiyin Zhang
Tingdong Li
Shengxiang Ge
Jun Zhang
Ningshao Xia
Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses
iScience
Biological sciences
Microbiology
Virology
Viral microbiology
title Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses
title_full Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses
title_fullStr Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses
title_full_unstemmed Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses
title_short Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses
title_sort bivalent rotavirus vp4∗ stimulates protective antibodies against common genotypes of human rotaviruses
topic Biological sciences
Microbiology
Virology
Viral microbiology
url http://www.sciencedirect.com/science/article/pii/S2589004222013712
work_keys_str_mv AT guoxingluo bivalentrotavirusvp4stimulatesprotectiveantibodiesagainstcommongenotypesofhumanrotaviruses
AT yuanjunzeng bivalentrotavirusvp4stimulatesprotectiveantibodiesagainstcommongenotypesofhumanrotaviruses
AT hanyang bivalentrotavirusvp4stimulatesprotectiveantibodiesagainstcommongenotypesofhumanrotaviruses
AT yijianli bivalentrotavirusvp4stimulatesprotectiveantibodiesagainstcommongenotypesofhumanrotaviruses
AT lianweiyang bivalentrotavirusvp4stimulatesprotectiveantibodiesagainstcommongenotypesofhumanrotaviruses
AT caoli bivalentrotavirusvp4stimulatesprotectiveantibodiesagainstcommongenotypesofhumanrotaviruses
AT feibosong bivalentrotavirusvp4stimulatesprotectiveantibodiesagainstcommongenotypesofhumanrotaviruses
AT shiyinzhang bivalentrotavirusvp4stimulatesprotectiveantibodiesagainstcommongenotypesofhumanrotaviruses
AT tingdongli bivalentrotavirusvp4stimulatesprotectiveantibodiesagainstcommongenotypesofhumanrotaviruses
AT shengxiangge bivalentrotavirusvp4stimulatesprotectiveantibodiesagainstcommongenotypesofhumanrotaviruses
AT junzhang bivalentrotavirusvp4stimulatesprotectiveantibodiesagainstcommongenotypesofhumanrotaviruses
AT ningshaoxia bivalentrotavirusvp4stimulatesprotectiveantibodiesagainstcommongenotypesofhumanrotaviruses